We just received data on a new analyst forecast for $ROP. William Blair gave a rating of 'Outperform' for $ROP.
$ROP Analyst Ratings
Wall Street analysts have issued reports on $ROP in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 05/05/2025
- Oppenheimer issued a "Outperform" rating on 04/28/2025
- Raymond James issued a "Strong Buy" rating on 04/28/2025
- Barclays issued a "Underweight" rating on 04/28/2025
- Cowen & Co. issued a "Buy" rating on 01/31/2025
To track analyst ratings and price targets for $ROP, check out Quiver Quantitative's $ROP forecast page.
$ROP Price Targets
Multiple analysts have issued price targets for $ROP recently. We have seen 3 analysts offer price targets for $ROP in the last 6 months, with a median target of $655.0.
Here are some recent targets:
- Brian Gesuale from Raymond James set a target price of $655.0 on 04/28/2025
- Christopher Glynn from Oppenheimer set a target price of $640.0 on 04/28/2025
- Joe Vruwink from Robert W. Baird set a target price of $665.0 on 01/31/2025
$ROP Congressional Stock Trading
Members of Congress have traded $ROP stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ROP stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$ROP Insider Trading Activity
$ROP insiders have traded $ROP stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $ROP stock by insiders over the last 6 months:
- LAURENCE NEIL HUNN (President and CEO) has made 0 purchases and 4 sales selling 30,000 shares for an estimated $17,174,100.
- JASON CONLEY (EVP, Chief Financial Officer) has made 0 purchases and 2 sales selling 6,000 shares for an estimated $3,498,720.
- JOHN K STIPANCICH (Executive VP, GC & Secretary) sold 1,000 shares for an estimated $578,040
- ROBERT D JOHNSON sold 940 shares for an estimated $528,092
- BRANDON L CROSS (VP and Corporate Controller) sold 750 shares for an estimated $433,372
- CHRISTOPHER WRIGHT sold 681 shares for an estimated $387,366
- RICHARD F WALLMAN sold 351 shares for an estimated $201,912
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ROP Hedge Fund Activity
We have seen 615 institutional investors add shares of $ROP stock to their portfolio, and 572 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,529,716 shares (+42.2%) to their portfolio in Q4 2024, for an estimated $795,222,862
- FRANKLIN RESOURCES INC removed 1,074,314 shares (-35.0%) from their portfolio in Q4 2024, for an estimated $558,482,132
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,072,072 shares (-16.4%) from their portfolio in Q4 2024, for an estimated $557,316,629
- DURABLE CAPITAL PARTNERS LP removed 485,764 shares (-43.1%) from their portfolio in Q4 2024, for an estimated $252,524,415
- JPMORGAN CHASE & CO added 360,632 shares (+54.5%) to their portfolio in Q4 2024, for an estimated $187,474,545
- BLACKROCK, INC. added 301,414 shares (+3.4%) to their portfolio in Q1 2025, for an estimated $177,707,666
- AMUNDI removed 298,703 shares (-49.1%) from their portfolio in Q4 2024, for an estimated $155,280,754
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
